English
Spanish
Welcome to LIFE’s one-stop-shop for national and international clinical guidelines for the diagnosis and management of fungal diseases.
The documents have been identified though literature searches, our own comprehensive files and the websites of reputable health agencies. These documents provide the most up to date recommendations from experts in their respective fields, based on scientific literature and research. Where no guidelines exist for a particular disease, comprehensive reviews are included which contain expert recommendations.
|
Last updated: 31 March 2020 |
||
|
Disease and subtype |
Prevention, diagnosis and treatment guidelines |
Commentary and supporting literature |
Invasive infections |
||
|
General |
ISHLT (2015) Diagnosis, international AGIHO (2018) prophylaxis, Germany RACP (2014) mould HSCT, Australasia RACP (2014) yeast haem-onc&ICU, Australasia RACP (2014) prophylaxis in HSCT, Australasia |
|
|
Cryptococcosis |
IDSA (2010) USA WHO (2018) international AIDSinfo (2015) USA RACP (2014) Australasia |
|
|
Histoplasmosis (disseminated) |
IDSA (2007) USA AIDSinfo (2013) USA |
|
|
Histoplasmosis (acute pulmonary) |
IDSA (2007) USA AIDSinfo (2013) USA |
|
|
Aspergillosis |
IDSA (2016) Practice guidelines and executive summary, USA Expert panel (2013) Middle East ESCMID-ECMM-ERS (2018) Europe, adults |
|
|
Rhinosinusitis |
ERS/EAACI (2012) international |
|
|
Mucormycosis |
ECMM/MSGERC (2019) Global ESCMID (2013) Europe |
|
|
Phaeohyphomycosis (black mould) |
|
|
|
Pneumocystis pneumonia (PCP/PJP) |
RACP (2014) prophylaxis and management, Australasia ECIL (2016) Europe: prevention; diagnosis; treatment |
|
Invasive candidiasis |
||
|
Invasive Candida infections |
ESCMID (2012) Diagnosis, Europe ESCMID (2012) Europe: Guideline development; non-neutropenic adults; prevention and treatment in neonates and children; adults with haematological malignancies, or after HSCT; haem-onc and ICU. RACP (2014) Australasia |
Tragiannidis et al (2014) update on guidelines for neonates and children |
|
Candidaemia |
IDSA (2016) |
Mellinghoff et al (2018) Equal Candida Score
Jack et al (2016) need to standardize candidaemia management |
|
Candida peritonitis |
ISPD (2011) prevention, international |
|
|
Rare invasive yeasts |
|
|
Mucosal candidiasis |
||
|
With HIV/AIDS |
ESCMID (2012) Europe |
|
|
Oral |
IDSA (2016) USA WHO (2014) international AIDSinfo (2015) USA |
|
|
Oesophageal |
IDSA (2016) USA AIDSinfo (2015) USA |
|
|
Balanoposthitis |
|
|
|
Vaginal |
AWMF (2015) Germany CDC (2017) USA |
|
Allergic conditions |
||
|
ABPA |
IDSA (2016) USA |
|
|
Rhinosinusitis |
|
|
|
Occupational lung disease |
|
|
|
SAFS |
|
|
|
Thunderstorm asthma |
HPA (2017) UK Alfred Health (2017) Australia |
|
Skin, hair & nail infections |
||
|
Tinea capitis |
WHO (2014) international ESPD (2010) paeds, Europe |
|
|
Tinea cruris |
WHO (2014) international |
|
|
Tinea manuum |
WHO (2014) international |
|
|
Tinea corporis (ringworm) |
|
|
|
Sporotrichosis |
IDSA (2007) USA |
|
|
Seborrheic dermatitis |
|
|
|
Onychomycosis |
||
|
Otitis extrena |
|
|
|
Pityriasis versicolor |
|
|
|
Chromoblastomycosis |
ESCMID (2014) Europe |
|
|
Laryngeal cryptococcosis |
|
|
|
Athlete’s foot |
|
|
|
Hyalohyphomycosis (Fusarium, Scedosporium) |
|
|
|
|
|
|
|
Malassezia |
|
|
Chronic lung or deep tissue infections |
||
|
Chronic pulmonary aspergillosis (CPA) |
IDSA (2016) USA |
Salzer et al (2016) Characterization of CPA patients according to new guidelines |
|
Chronic cavitary pulmonary histoplasmosis |
IDSA (2007) USA |
|
|
Deep-seated mycosis |
Japan (2014) Japan |
|
|
Coccidioidomycosis |
IDSA (2016) USA AIDSinfo (2013) USA |
|
|
Paracoccidioidomycosis |
Brazil (2017) Brazil |
|
|
Blastomycosis |
IDSA (2008) USA |
|
|
Granulomatous invasive fungal rhinosinusitis |
|
|
|
Fungal ball (sinus) |
IDSA (2008) USA |
Yoon et al (2017) retrospective of 538 cases, with recommendations |
|
Fungal keratitis |
International (2009) international |
|
|
Endemic mycoses (Histo, Blasto, Cocci) |
AST-ID (2019) solid organ transplant recipients |
|
Other guidelines |
||
|
Diagnostics |
IDSA /ASM utilisation of microbiology laboratories (2018) USA |
|
|
Antifungals |
CPIC (2016) voriconazole and CYP2C19 |
Morgan et al (2016) review of guidelines for antifungal treatment of haem-onc paeds |
|
Professional skills |
Writing SOPs in resource-poor settings (2016) in PLOS NTDs Competency guidelines for PHL professionals (2015) CDC MMWR, USA |
|
|
Implementing guidelines |
|
Overcoming the obstacles of implementing infection prevention and control guidelines |
|
IRIS |
IRIS (2015) India |
|
|
TDM |
|
|
|
Veterinary |
|
|
* The SWAB guidelines are different from other invasive aspergillosis guidelines as they are the first for:
- ICU and severe influenza and IA – these could also be highlighted and a blog for AW
- Initial therapy for those areas with a high azole resistance frequency in A. fumigatus
|
|
|
|
|
|
|
|
|
|
|
|
.png)
